ENYO PHARMA
ENYO Pharma is a biopharmaceutical company incorporated in Jan, 2014, by four scientists of the Infectiology Research Center in Lyon, France, and three seeding partners (2 privates and 1 public). The company is based in the Infectiology Center of Lyonbiopรดle in Lyon, France and maintains tight collaborations with the seminal Inserm team and the BSL4 laboratory Inserm-Jean Mรฉrieux. ENYO Pharma has licensed several Inserm patents issued from the discoveries of the founding scientists and devel... oped a unique platform for the identification of intracellular therapeutic targets and molecules. The company is developing treatments against the most important viruses and is thriving to become a global leader in anti-virals. Research and Development is currently focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company plans to conduct its molecules to Phase II clinical trials.
ENYO PHARMA
Industry:
Biopharma Biotechnology Medical
Founded:
2014-01-01
Address:
Lyon, Rhone-Alpes, France
Country:
France
Website Url:
http://www.enyopharma.com
Total Employee:
11+
Status:
Active
Contact:
33437700219
Email Addresses:
[email protected]
Total Funding:
64.5 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Advisors List
Current Employees Featured
Founder
Investors List
InnoBio
InnoBio investment in Series B - ENYO Pharma
Bpifrance
Bpifrance investment in Series B - ENYO Pharma
Morningside Venture Investments
Morningside Venture Investments investment in Series B - ENYO Pharma
OrbiMed
OrbiMed investment in Series B - ENYO Pharma
Sofinnova Investments
Sofinnova Investments investment in Series B - ENYO Pharma
Inserm Transfert Initiative
Inserm Transfert Initiative investment in Series B - ENYO Pharma
Andera Partners
Andera Partners investment in Series B - ENYO Pharma
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - ENYO Pharma
Sofinnova Partners
Sofinnova Partners investment in Series A - ENYO Pharma
Official Site Inspections
http://www.enyopharma.com Semrush global rank: 8.82 M Semrush visits lastest month: 249
- Host name: 98-116-176-185.rev.solware.fr
- IP address: 185.116.176.98
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris